During the past decade, Columbia IMPAACT Center (4101) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia IMPAACT Center (4101)" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Columbia IMPAACT Center (4101)" are "ADHD" (1 trials), "HIV" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "Columbia IMPAACT Center (4101)" in a lesser frequency.

The vast majority of trials in "Columbia IMPAACT Center (4101)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Columbia IMPAACT Center (4101)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Columbia IMPAACT Center (4101), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia IMPAACT Center (4101), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".